Cyclezyme AB (XSAT:CYCLE) Interest Expense: kr-0.04 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CYCLE Cyclezyme AB XSAT:CYCLE
8 GF Score
Price kr26.20
! 3 Warning Signs
View Full Analysis

What is Cyclezyme AB Interest Expense?

Cyclezyme AB XSAT:CYCLE -1.87% 8 Interest Expense is kr-0.04 Mil as of Mar. 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cyclezyme AB's interest expense for the three months ended in Mar. 2026 was kr -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cyclezyme AB's Operating Income for the three months ended in Mar. 2026 was kr -0.83 Mil. Cyclezyme AB's Interest Expense for the three months ended in Mar. 2026 was kr -0.01 Mil. Cyclezyme AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cyclezyme AB  (XSAT:CYCLE) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cyclezyme AB's Interest Expense for the three months ended in Mar. 2026 was kr-0.01 Mil. Its Operating Income for the three months ended in Mar. 2026 was kr-0.83 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was kr0.18 Mil.

Cyclezyme AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Cyclezyme AB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cyclezyme AB Interest Expense Historical Data

* Premium members only.

The historical data trend for Cyclezyme AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclezyme AB Interest Expense Chart

Cyclezyme AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial 0.00 0.00 -0.02 -0.06 -0.04

Cyclezyme AB Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.01
XSAT:CYCLE
8GF Score
Cyclezyme AB XSAT:CYCLE
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyclezyme AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of kr-0.04 Mil mean?
Cyclezyme AB (XSAT:CYCLE) has a Interest Expense of kr-0.04 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cyclezyme AB and its competitors.
Is Cyclezyme AB's Interest Expense too high?
Cyclezyme AB's current Interest Expense is kr-0.04 Mil. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's Interest Expense compare to LIN and SHW?
Cyclezyme AB's Interest Expense of kr-0.04 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Chemicals company?
A good Interest Expense depends on the Chemicals industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cyclezyme AB and its competitors. Cyclezyme AB's current Interest Expense is kr-0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current Interest Expense of kr-0.04 Mil. The current Interest Expense is kr-0.04 Mil. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current Interest Expense is kr-0.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyclezyme AB Business Description

Address Scheelevagen 22, Lund, SWE, 223 63
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score

Get the complete analysis for XSAT:CYCLE

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr26.20
Price